Facts about Mural Oncology plc (MURA) Stock that you might not know
Rodman & Renshaw raised the price target for the Mural Oncology plc (NASDAQ:MURA) stock to “a Buy”. The rating was released on June 28, 2024, according to finviz. The latest trade, Performances and Moving Averages give us the following Picture The firm’s stock price fluctuated -3.09% within the last five trades and -6.27% within the […]
